Ambu ROE 2022-2024 | AMBBY
Current and historical return on equity (ROE) values for Ambu (AMBBY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Ambu ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-06-30 |
$0.06B |
$0.83B |
8.00% |
| 2024-03-31 |
$0.05B |
$0.82B |
6.63% |
| 2023-12-31 |
$0.03B |
$0.78B |
4.30% |
| 2023-09-30 |
$0.02B |
$0.77B |
3.22% |
| 2023-06-30 |
$-0.01B |
$0.77B |
-1.18% |
| 2023-03-31 |
$-0.01B |
$0.75B |
-1.73% |
| 2022-12-31 |
$0.01B |
$0.57B |
2.14% |
| 2022-09-30 |
$0.01B |
$0.62B |
2.11% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Hospitals |
$3.332B |
$0.784B |
|
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark.
|
